Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results

Published 19/12/2023, 17:54
© Reuters.  Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results
FDS
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 150 points on Tuesday.

The Dow traded up 0.46% to 37,476.21 while the NASDAQ rose 0.41% to 14,966.74. The S&P 500 also rose, gaining, 0.38% to 4,758.55.

Check This Out: Cisco Systems, Electronic Arts And 2 Other Stocks Insiders Are Selling

Leading and Lagging Sectors

Materials shares rose by 1% on Tuesday.

In trading on Tuesday, information technology shares fell by 0.1%.

Top Headline

Shares of FactSet Research Systems Inc (NYSE: FDS) gained on Tuesday after the company reported earnings results for its first quarter.

FactSet Research reported quarterly sales growth of 7.4% Y/Y to $542.2 million, marginally beating the consensus of $540.36 million. Adjusted EPS of $4.12 beat the consensus of $4.11.

FactSet lowered FY24 revenue outlook to $2.20 billion-$2.21 billion (from $2.21 billion-$2.23 billion) vs. $2.22 billion estimate and adj. EPS to $15.60-$16.00 (from $15.65-$16.15) vs. consensus of $16.08.

Equities Trading UP

Compugen Ltd. (NASDAQ: CGEN) shares shot up 159% to $1.8901 after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program.

Shares of Intelligent Bio Solutions Inc. (NASDAQ: INBS) got a boost, surging 57% to $0.4391. Intelligent Bio Solutions received National Association of Testing Authorities accreditation for its Intelligent Fingerprinting Drug Screening Solution.

Infobird Co., Ltd (NASDAQ: IFBD) shares were also up, gaining 23% to $1.66 after the company inked a new business cooperation in software development of information technology system.

Equities Trading DOWN

Motus GI Holdings, Inc. (NASDAQ: MOTS) shares dropped 45% to $1.18 after the company priced its $5 million public offering.

Shares of BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) were down 44% to $0.3849 after the company reported pricing of $1.5 million registered direct offering.

Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) was down, falling 20% to $2.43 after the company disclosed the pricing of $5.2 million underwritten public offering.

Also Check This Out: How To Earn $500 A Month From General Mills Stock Ahead of Quarterly Earnings Report

Commodities

In commodity news, oil traded up 0.8% to $73.08 while gold traded up 0.7% at $2,055.30.

Silver traded up 1.2% to $24.40 on Tuesday while copper rose 1.9% to $3.9245.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.28%, London’s FTSE 100 gained 0.16% while Spain’s IBEX 35 Index rose 0.29% The German DAX rose 0.44% French CAC 40 rose 0.02%, while Italy’s FTSE MIB Index rose 0.23%.

Annual inflation rate in the Eurozone eased to 2.4% in November from 2.9% in the previous month.

Asia Pacific Markets

Asian markets closed mostly higher on Tuesday, with Japan’s Nikkei 225 gaining 1.41%, Hong Kong’s Hang Seng Index declining 0.75% and China’s Shanghai Composite Index gaining 0.05%. India’s S&P BSE Sensex, meanwhile, rose 0.17%.

Hong Kong’s unemployment rate came in unchanged at 2.9% for the three months ending Nov. 2023. The Bank of Japan held its key short-term interest rate at -0.1% during its latest meeting.

Economics

Building permits in the U.S. declined by 2.5% to an annual rate of 1.460 million in November, down from market estimates of 1.470 million.

U.S. housing starts surged 14.8% month-over-month to an annualized 1.56 million in November, compared to market estimates of 1.36 million.

Now Read This: Top 5 Financial Stocks That May Keep You Up At Night In December

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.